Navigation Links
A Genetic Approach For Crohn's And Colitis Disease Is Financed By The Jeffrey Epstein VI Foundation
Date:7/3/2012

NEY YORK, July 3, 2012  /PRNewswire/ -- The Jeffrey Epstein VI Foundation, which actively supports science research, has given substantial support to the Crohn's and Colitis Foundation of America to continue its Genetic Initiative to find a cure for the diseases.

Crohn's is a chronic inflammatory condition of the gastrointestinal tract. Every year, about 700,000 Americans are diagnosed, the majority being between the ages of 15 and 35. Crohn's affects the end of the small bowel, or ileum, the beginning of the colon and parts of the gastrointestinal tract. Ulcerative colitis affects the colon or large intestine.

The cause of Crohn's and Colitis is uncertain but the chronic inflammation stems from the immune system attacking microbial antigens in the gastrointestinal tract. Because of this, the disease is classified as an autoimmune disorder.

What is certain however is that Crohn's has a strong genetic component. Siblings are 30 times more likely to develop Crohn's than the general population. Children of those affected, are 3 to 20 times more likely to develop the disease and twins show a concordance of over 55%.

The Genetic Initiative at the Crohn's and Colitis Foundation of America, which recently received funding from The Jeffrey Epstein VI Foundation, is by far the most comprehensive effort of its kind to isolate the mutated genes that lead to the disease. The Initiative employs a dream team of specialists from different fields to identify genetic mutations and the chain of subsequent pathologies that cause Crohn's and Colitis. The Initiative is headed by Dr. Ramnik Xavier, Chairman of the Department of Gastroenterology at Massachusetts General Hospital in Boston. Xavier's laboratory has identified the largest number of genes associated with Crohn's to date. He is also a founding member of the Center for Computational and Integrative
'/>"/>

SOURCE www.jeffreyepstein.org
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. First Genetic Cure For Cancer Anchors Provocative New Thriller
2. Applied Genetics Initiates Commercial Operation
3. BioRealm to Develop Universal Genetic Screening Tool for Tobacco Addiction and Treatment
4. U.S. Senate Urged to Increase Federal Funding for Research into Hereditary Angioedema, a Rare and Serious Genetic Disorder
5. Study suggests expanding the genetic alphabet may be easier than previously thought
6. Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools
7. JS Genetics announces launch of XCAT-KS, a bloodless, cheek swab test for the diagnosis of Klinefelter syndrome and other Male sex chromosome aneuploidies
8. Global Genetic Engineering Industry
9. Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrigs Disease)
10. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
11. Khan Academy and 23andMe Partner to Promote Genetics Education on DNA Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... laboratory information management systems market is a rapidly growing ... due to factors such as rising pressure to comply ... and increasing government support for adoption of HCIT solutions ... the market focus on technological advancements to further the ...
(Date:1/22/2015)... 2015 Dr. Greg Leyer of UAS Labs ... Natural Supplements Pre-Conference seminar on probiotics in San Diego, CA. ... continuing education conference for health care professionals. This year’s pre-conference ... of probiotics in health. Dr. Leyer spoke about the emerging ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... WOBURN, Mass., Nov. 26 Covaris Incorporated today,announced that ... shipment,of its 500th instrument unit and continued another successful ... Covaris is both,strengthening its sales and marketing organization as ... , The Covaris ...
... TOKYO and CAMBRIDGE, England, November 26 Sosei,Group Corporation ... that it has out-licensed its IP and Know How,relating ... ("Treague"), a,Cambridge, UK based pharma company, for the treatment ... Mefloquine is a highly efficacious anti-malarial drug that ...
... ANDS ) announced today that it will present at ... 3, 2008 at 9:30 a.m. EST (6:30 a.m. PST) at the ... Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will ... ANA598 and ANA773 in hepatitis C and ANA773 in cancer. , ...
Cached Biology Technology:Covaris Installed Instrument Base Reaches 500 Units 2Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria 2Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference 2
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB SM ... (GCP) audit to confirm its adherence to current U.S. ... HITLAB to conduct regulated smart device and smart phone ... and research quality. "HITLAB is determined to ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally transforming ... than at international borders. Over the past decade, ePassports, ... travelers to self process through border control via eGates ... number of airports, seaports, and land borders across the ...
(Date:12/11/2014)... 09, 2014 Research and Markets , ... ) has announced the addition of the "Biometrics ... One major trend emerging in this ... biometric systems utilize more than one characteristic of an ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... (OTC,Bulletin Board: BMRX), a leading developer and supplier ... executed an,agreement with Biometric Solutions, LLC, to co-develop ... biometric technology to consumers at,an accelerated rate, growing ... LLC has had successful engineering efforts on,behalf of ...
... are the first to observe the dynamic, ratchet-like movements ... proteins from genetic blueprints. Their study, published ... in the interplay of molecules that allows cells to ... use a variety of tools to build proteins, beginning ...
... of niacin (vitamin B3) in the liver, which should provide ... HDL-cholesterol levels in the blood and thus lower the risk ... levels, the mechanism of how it works has been mysterious, ... production. Recent work had uncovered that a component of ATP ...
Cached Biology News:bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology 2bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology 3Researchers observe spontaneous 'ratcheting' of single ribosome molecules 2Researchers observe spontaneous 'ratcheting' of single ribosome molecules 3
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C...
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
... (phospho S207) ( Abpromise for ... Antigen: Synthetic phosphopeptide derived from ... of Serine 207 (V-D-S P -V-A). ... 5608 Swiss ...
Rabbit polyclonal to Reptin/TIP49B/RUVB2 ( Abpromise for all tested applications). Antigen: Synthetic peptide (Human) Entrez Gene ID: 10856 Swiss Protein ID: Q6FIB9...
Biology Products: